Metagenomi, Inc. Common Stock
MGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $27 | $141 | $184 | $39 |
| Short-Term Investments | $221 | $131 | $178 | $69 |
| Receivables | $1 | $2 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $5 | $3 | $0 |
| Total Curr. Assets | $258 | $278 | $367 | $109 |
| Property Plant & Equip (Net) | $58 | $65 | $33 | $22 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $3 | $16 | $8 | $6 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $5 | $7 | $5 |
| Total NC Assets | $67 | $87 | $48 | $33 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $325 | $365 | $414 | $142 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $2 | $1 |
| Short-Term Debt | $6 | $3 | $2 | $1 |
| Tax Payable | $0 | $3 | $2 | $0 |
| Deferred Revenue | $23 | $49 | $34 | $16 |
| Other Curr. Liab. | $8 | $11 | $10 | $7 |
| Total Curr. Liab. | $37 | $69 | $49 | $25 |
| LT Debt | $40 | $45 | $17 | $48 |
| Deferred Rev, NC | $10 | $31 | $76 | $24 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $5 | $347 | $77 |
| Total NC Liab. | $52 | $81 | $440 | $149 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $46 | $45 | $19 | $19 |
| Total Liabilities | $90 | $150 | $489 | $175 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $351 | $0 | $0 |
| Common Stock | $0 | $0 | $3 | $1 |
| Retained Earnings | -$223 | -$145 | -$77 | -$33 |
| AOCI | $1 | $9 | -$0 | -$0 |
| Other Equity | $457 | $0 | $0 | $0 |
| Total Equity | $235 | $215 | -$74 | -$33 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $325 | $365 | $414 | $142 |
| Net Debt | $18 | -$92 | -$166 | $10 |